USG Whole Abdomen Report Analysis — Mrs. Manorma Devi, 60F | Date: 01.04.2026

📋 Report Summary at a Glance

🔍 Detailed Finding-by-Finding Analysis

1. Gallbladder — The Most Clinically Urgent Finding

• Normal GB wall thickness is <3 mm (0.3 cm). A wall of 0.77 cm (7.7 mm) is markedly thickened — more than double the upper limit.
• Edematous thickening + multiple stones + sludge = Cholelithiasis with acute-on-chronic cholecystitis.
• The radiologist has rightly advised CECT upper abdomen to assess GB wall status — this is to rule out gangrenous cholecystitis, pericholecystic collection, empyema, or rarely GB carcinoma (which can mimic inflammatory thickening).
• The largest stone at 1.96 cm is clinically significant — stones >1.5 cm have higher risk of complications (Mirizzi syndrome, fistula, ileus).
• Sludge in the GB lumen further supports stasis and ongoing inflammation.

2. Mild Hepatomegaly (Rt lobe 15.1 cm CC)

• Normal right lobe craniocaudal span is ≤15 cm. At 15.1 cm, this is borderline/mild hepatomegaly.
• The key reassurance is normal echotexture — this rules out fatty infiltration, cirrhosis, or infiltrative disease on USG.
• However, normal echotexture on USG does not definitively exclude early NAFLD or mild hepatitis.
• No intrahepatic ductal dilatation (no IHD) rules out obstructive cholestasis.
• Normal portal vein and CBD are important — no portal hypertension pattern.

3. Small Left Kidney (7.37 × 3.30 cm)

• Normal kidney length: 9–12 cm. Left kidney at 7.37 cm is notably small (~2 cm smaller than the right).
• Normal echotexture is critically important — it means this is likely congenital renal hypoplasia rather than acquired atrophy (which typically shows increased echogenicity).
• CMD (corticomedullary differentiation) is intact — supportive of a non-destructive etiology.
• No hydronephrosis, no stones — rules out obstructive nephropathy.
• A kidney smaller by >2 cm than its contralateral counterpart raises concern for renovascular disease (renal artery stenosis causing ischemic nephropathy) as well, even with preserved echotexture.

As per the Washington Manual of Medical Therapeutics: "A discrepancy in kidney size of >2 cm suggests chronic disease in a unilateral kidney, such as that seen in renal artery stenosis with atrophy of the affected kidney."

🏥 How Should You Proceed as a Practicing Doctor?

IMMEDIATE PRIORITIES

A. Gallbladder Disease — Act Now

1. CECT Upper Abdomen (as advised by radiologist) — this is mandatory before planning surgery. It will:
   • Confirm/exclude gangrenous cholecystitis or empyema
   • Assess pericholecystic fat stranding
   • Rule out GB carcinoma (diffuse mural thickening in a 60F must always have malignancy excluded — GB Ca is the most common biliary malignancy in India, especially in north India, and more common in women >50)
   • Evaluate liver parenchyma more precisely
2. Bloodwork — Order urgently:
   • CBC with differential (leukocytosis?), CRP/ESR
   • LFT (AST, ALT, ALP, GGT, Bilirubin — total + direct) — elevated ALP/GGT may point to biliary pathology
   • Serum amylase/lipase — to rule out concurrent biliary pancreatitis
   • RFT (urea, creatinine, eGFR) — baseline for the small left kidney
   • Urine routine + microscopy
   • PT/INR (surgical planning)
   • Blood glucose (comorbidity screen in 60F)
   • CA 19-9 (consider if CECT raises suspicion of malignancy)
3. Pain management and dietary advice:
   • Low fat diet, small frequent meals
   • Tab. Drotaverine / Antispasmodic for biliary colic
   • If symptomatic (fever, RUQ pain, vomiting): NPO, IV fluids, IV antibiotics (Cefoperazone + Sulbactam or Piperacillin-Tazobactam per Rosen's Emergency Medicine guidance)
4. Surgical Referral — Laparoscopic Cholecystectomy:
   • This patient has symptomatic cholelithiasis with cholecystitis — definitive treatment is laparoscopic cholecystectomy.
   • Refer to a surgical unit. The Tokyo Guidelines and current evidence (Fugazzola et al., 2024 — EClinicalMedicine, PMID 39469538) recommend early cholecystectomy (within 72 hours for Grade I–II acute cholecystitis) over delayed interval surgery, which has higher complication rates.
   • Pre-op CECT is useful here given the marked GB wall thickening.

B. Small Left Kidney — Investigate to Establish Cause

1. Renal workup:
   • Serum creatinine and eGFR — critical. The right kidney appears to be compensating.
   • Doppler USG of renal arteries (bilateral) — to rule out left renal artery stenosis. This is non-invasive and should be the next step.
   • Urine for protein — chronic renal parenchymal disease, even unilateral, can cause proteinuria.
   • If Doppler is abnormal → refer to nephrology / urology for CT angiography.
   • If Doppler normal + normal echotexture → likely congenital hypoplasia, no specific treatment but monitor BP (unilateral small kidney with RAS is a well-known secondary cause of hypertension).
2. Blood pressure monitoring — renovascular hypertension is a key concern with a small kidney. Check BP at every visit.

C. Hepatomegaly — Monitoring and Workup

1. Hepatitis serology — HBsAg, Anti-HCV (rule out chronic viral hepatitis in a 60F)
2. Fasting lipid profile, blood glucose — screen for metabolic syndrome/NAFLD
3. If LFTs are deranged → fibroscan or repeat USG after 3 months once the acute GB pathology is treated (GB inflammation itself can cause reactive liver enzyme elevation)

CLINICAL CONCERN WORTH FLAGGING — GB Carcinoma

Summary Action Plan

Cholecystectomy: Techniques from Standard to Most Advanced

The Evolution at a Glance

Open (1882) → Laparoscopic (1985/1987) → SILS (2000s) → Robotic (2006+) → NOTES → ICG-guided (2010s+)

1. Open Cholecystectomy — The Historical Standard

• Conversion from laparoscopy is required (failed dissection, uncontrolled bleeding, extreme inflammation)
• Severe portal hypertension or coagulopathy
• Extensive adhesions from prior upper abdominal surgery
• Perforation with peritonitis requiring laparotomy

2. Conventional Laparoscopic Cholecystectomy (LC) — The Current Gold Standard

• 4-port approach: 12 mm umbilical port (specimen extraction) + three 5 mm ports (RUQ)
• Patient in steep reverse Trendelenburg (Fowler position)
• Gallbladder fundus retracted cephalad, infundibulum laterally
• Critical View of Safety (CVS) obtained before any clipping — gold standard for bile duct injury prevention
• Cystic duct + cystic artery clipped and divided
• Specimen extracted in a retrieval bag via umbilical port

Defined as: Two and only two structures entering the gallbladder, lower 1/3 of GB dissected from liver to expose cystic plate, and a cleared hepatocystic triangle. This is the single most effective means of preventing bile duct injury. (Sabiston / Current Surgical Therapy 14e)

3. Intraoperative Cholangiography (IOC) — A Vital Adjunct

• Delineate biliary anatomy when unclear
• Identify CBD stones
• Confirm anatomy in difficult dissections

4. ICG Fluorescent Cholangiography — Modern Safety Enhancement ⭐

• Real-time, dynamic visualization of CBD, cystic duct, hepatic ducts
• No radiation (unlike IOC)
• Works with both laparoscopic and robotic platforms
• No iodine allergy concerns

Per Sabiston: "FC offers a potentially detailed anatomic mapping of extrahepatic biliary structures and can be a useful adjunct to the critical view of safety technique. Dynamic, real-time NIR light capability is built into many modern laparoscopic and robotic cameras."

5. Single-Incision Laparoscopic Surgery (SILS/SILC) — Scarless Option

• Superior cosmesis
• Possibly less post-op pain

• Technically demanding (instrument crowding, lack of triangulation)
• Longer operative time
• Higher hernia rate at the umbilical port site
• No proven superiority in outcomes over 4-port LC

6. Robotic-Assisted Cholecystectomy (RAC) — The Most Technologically Advanced ⭐⭐

1. Qadri et al., 2025 (PMID 41354898) — 1.77 million patients, 25 studies:
   • Complication rates: equivalent to LC
   • Bile duct injury: equivalent
   • Readmission: equivalent
   • Length of stay: equivalent (-0.02 days difference, NS)
   • Conversion to open: significantly lower (OR 0.35, p<0.0001)
   • Operative time: 12.65 min longer on average
2. Camarotti et al., 2026 (PMID 41417656) — 1,073,587 patients in non-elective (acute) settings:
   • RAC = lower conversion to open surgery (OR 0.66)
   • Other outcomes: equivalent to LC
3. Delpino et al., 2026 (PMID 42056779) — 7.5 million patients:
   • "No demonstrable difference in outcomes between robotic and laparoscopic approaches"

• Difficult/inflamed gallbladders (like Manorma Devi's case)
• Surgeons with robotic training
• Centers where platforms are available

7. NOTES (Natural Orifice Transluminal Endoscopic Surgery) — Experimental Frontier

8. Subtotal Cholecystectomy — The Bailout for Dangerous Cases

Summary Comparison Table

For Manorma Devi — Which Approach?

• Best approach: Laparoscopic cholecystectomy + ICG fluorescent cholangiography, performed early (within 72 hours of acute presentation per Tokyo Guidelines, Grade I–II)
• Robotic-assisted cholecystectomy is a valid upgrade if available at your center — the lower conversion rate to open surgery is a real clinical advantage given her inflamed, thickened GB
• Subtotal cholecystectomy should be planned as a bail-out if the hepatocystic triangle is frozen due to inflammation on CECT
• NOTES is not appropriate here
• ICG (NIR fluorescence) is strongly recommended given the anatomy may be distorted — it provides real-time biliary mapping without cannulation